GREY:ATBPF - Post by User
Comment by
Pragmatiston Apr 23, 2021 4:11pm
171 Views
Post# 33057084
RE:A couple of "stupid" questions
RE:A couple of "stupid" questionswoundedknee wrote: This almalgamation looks like a good idea to me, but saying that does anyone know if there is any new shares issued in this transaction?(dilution) And I feel foolish asking this, but we have proven safety, effacy, and to a great degree the dosage in P2, so what does P3 add to this and what are the circumstances during p3 trials that we should worry about? good weekend all
You probably won't get an answer to your second question as pers here are reluctant to post anything that might be considered as negative. I have my concerns, but I too will keep them to myself. You just have to look at things with a critical eye and see where the hiccups might lie. And maybe do a little research. I literally have spent hundreds of hours looking into ATE and biotech in general...it's a fascinating field, and I fortunately have the time.
Having said that, I see the next 9-12 mths as being very positive which includes the possibility of another deal. SP should receive a pop upon a Nasdaq uplist and should embark on a steady climb sometime after the completion of recruitment for the pivotal trial, in anticipation of positive results. Other catalysts such as a successful post PH 2 meeting are less important...just another check in the box. I'm personally not concerned about any interim price drop due to amalgamation or other. We will get it all back in the fall. Just my view.